List of insiders holdings for Sarepta Therapeutics Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Insider Holder NameReport
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
BLACK BEAR OFFSHORE MASTER FUND LP
10% Owner
2009-06-02 12:59:099,914,211
0
9,914,211Form 3
Rockall Emerging Markets Master Fund Ltd
O'Driscoll Conor
Egan Con
Meldrum Asset Management LLC
May be deemed 10% group member
2012-02-13 11:27:438,648,382
0
8,648,382Form 13G
EASTBOURNE CAPITAL MANAGEMENT LLC
10% Owner
2010-03-08 17:30:555,659,211
0
5,659,211Form 4
HAYWOOD GEORGE WEAVER
Haywood Cheryl
May be deemed 10% group member
2012-02-13 16:19:215,263,813
0
5,263,813Form 13G
Barry Richard
Director
2022-03-08 20:03:402,933,396
200,000
3,133,396Form 4
MEDTRONIC INC
10% Owner
2005-02-14 17:30:173,000,000
0
3,000,000Form 13D
kole Ryszard
SVP/Discovery Research
2010-02-11 20:32:102,232,926
0
2,232,926Form 4
BURGER DENIS R
Chief Executive Officer
2007-04-05 15:39:501,180,000
0
1,180,000Form 4
TIMMINS ALAN P
President & COO
2008-03-03 16:05:52968,382
1500
969,882Form 4
LINSLEY PETER S
SVP & Chief Scientific Officer
2011-05-16 19:20:21800,000
0
800,000Form 4
WEBBER MARK MILES
CFO
2008-03-03 16:06:01529,946
0
529,946Form 4
Christopher Nishan Garabedian
President and CEO
2015-03-03 18:47:35402,552
0
402,552Form 4
JOHNSON GRAHAM
Sr VP Preclinical Dev & Rsrch
2010-08-25 17:03:42400,000
0
400,000Form 4
Hudson Leslie
Former CEO
2010-08-02 19:28:38384,559
0
384,559Form 4
OHANLEY PETER D
Sr. Vice President
2008-03-03 16:05:38382,500
0
382,500Form 4
INGRAM DOUGLAS S
President & CEO
2021-11-17 18:24:20365,082
0
365,082Form 4
Krieg Arthur M
SVP Chief Scientific Officer
2014-01-15 21:32:33275,000
0
275,000Form 4
Chambers Michael Andrew
Director
2022-09-15 08:00:25108,178
75,194
183,372Form 4
BEHRENS M KATHLEEN
Director
2022-12-21 09:05:10158,470
10000
168,470Form 4
Toshav Bracha Ephrat
Sr VP & General Counsel
2011-09-02 20:30:24150,000
0
150,000Form 4
Wood Joan
VP Human Resources
2016-09-30 21:55:47113,426
0
113,426Form 3
Stehman-Breen Catherine
SVP Chief Medical Officer
2017-04-05 17:06:26100,000
0
100,000Form 4
HORN JOSEPH B
Vice President of Cardiology
2006-03-23 20:50:34100,000
0
100,000Form 4
HICKS JAMES B
Director
2007-05-24 18:38:0299,334
0
99,334Form 4
FARA JOHN W PHD
Director
Director
2008-05-21 21:56:5093,834
0
93,834Form 4
CHASE ANTHONY R
Director
2015-03-03 18:47:2582,194
0
82,194Form 4
Estepan Ian Michael
Chief Financial Officer
2022-03-08 20:02:5380,671
0
80,671Form 4
BOWMAN JACK L
Director
2007-05-24 18:37:2378,334
0
78,334Form 4
Aphale Jayant
VP Technical Operations
2016-09-21 21:31:5276,490
0
76,490Form 4
Kaye Edward M. MD
Director
2017-08-07 16:39:2371,229
0
71,229Form 4
BOYLE J DAVID II
CEO
2010-08-27 18:02:0670,282
0
70,282Form 4
Ciambrone William
EVP
2022-03-08 20:01:3070,099
0
70,099Form 4
Basi Guriqbal S.
SVP Chief Scientific Officer
2018-03-07 18:00:5670,000
0
70,000Form 4
Rodino-Klapac Louise
Head of R & D CSO
2022-11-21 20:02:0267,998
0
67,998Form 4
HENNEY CHRISTOPHER S
Director
2009-04-02 21:04:3060,000
0
60,000Form 4
JACOBSEN MICHAEL A
VP of Finance and PAO
2012-08-27 21:30:0756,000
0
56,000Form 4
MILE MELINDA G
Controller and PAO
2011-09-02 20:29:4050,000
0
50,000Form 4
Cumbo Alexander
EVP Chief Commercial Officer
2020-02-28 20:01:3746,067
3441
49,508Form 4
Price Ben Gil
Director
2016-03-16 20:07:0542,830
0
42,830Form 4
Howton David T
EVP General Counsel
2020-06-22 21:17:5639,579
0
39,579Form 4
Ruddon Raymond W
Director
2004-05-12 17:44:2533,000
0
33,000Form 3
Mahatme Sandesh
EVP CFO & CBO
2020-07-09 20:00:2220,260
12,012
32,272Form 4
Ruff Shamim
SVP Chief Regulatory Affairs
2018-05-24 18:06:1531,936
0
31,936Form 4
Arif Bilal
Chief Tech Ops Officer
2023-01-04 20:03:0530,000
0
30,000Form 4
O'Neill Gilmore Neil
EVP R & D & CMO
2021-03-10 20:02:4228,546
0
28,546Form 4/A
Brown Ryan Edward
SVP General Counsel
2022-06-03 20:00:1525,841
0
25,841Form 4
WELLER DWIGHT D
Sr. VP Chemistry & Mfg.
2010-08-24 20:01:4925,000
0
25,000Form 4
SHREWSBURY STEPHEN B
SVP/Regulatory Affairs
2010-08-24 20:00:3525,000
0
25,000Form 4
Medeiros Paul
SVP Business Development
2010-08-24 19:59:1425,000
0
25,000Form 4
IVERSEN PATRICK L
Sr VP of Research & Devlopment
2010-08-24 19:55:5725,000
0
25,000Form 4
Wigzell Hans Lennart Rudolf
Director
2022-03-08 20:05:0724,548
0
24,548Form 4
HODGMAN JOHN
Director
2015-03-03 18:47:5821,333
0
21,333Form 4
Bratica Joseph
Principal Financial Officer
2020-12-14 20:00:2820,425
0
20,425Form 4
FORREST K MICHAEL
Outside Director
Director
2009-10-19 21:35:2020,000
0
20,000Form 4/A
CASEY MICHAEL D
Director
2009-10-19 21:35:0820,000
0
20,000Form 4/A
Nicaise Claude
Director
2022-03-08 20:07:1219,882
0
19,882Form 4
Goolsbee William Alden
Director
2016-03-02 20:57:2018,666
0
18,666Form 4
GRAY MARY ANN
Director
2022-03-08 20:06:2017,433
0
17,433Form 4
Kress Jean-Paul
Director
2017-03-14 21:42:4714,350
0
14,350Form 4
MARTIN JOHN C
Director
2021-03-05 20:04:1713,431
0
13,431Form 4
Boor Kathryn Jean
Director
2022-06-06 20:24:3613,237
0
13,237Form 4
BONNEY MICHAEL W
Director
2020-02-28 20:06:3112,811
0
12,811Form 4
Mayo Stephen
Director
2022-11-21 20:00:556387
0
6387Form 4
Martignetti Anthony
See Remarks
2013-06-07 06:01:405000
0
5000Form 4